Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench

BACKGROUND: Despite the known risk of diabetes-induced cardiac fibrosis, less is known about whether diabetes causes an altered cardiac phenotype independent of coronary atherosclerosis. Peroxisome proliferator-activated receptor δ (PPARδ), a versatile regulator of metabolic homeostasis, may be a po...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Wei-Ting, Cheng, Juei-Tang, Chen, Zhih-Cherng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983091/
https://www.ncbi.nlm.nih.gov/pubmed/27519769
http://dx.doi.org/10.1186/s12933-016-0430-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983091/
https://www.ncbi.nlm.nih.gov/pubmed/27519769
http://dx.doi.org/10.1186/s12933-016-0430-5

Ejemplares similares